Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway
International Immunopharmacology · 2024-06 · 135 · 112286
DOI: 10.1016/j.intimp.2024.112286 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Min Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunmi…. Hauptthemen laut MEDLINE: Dextran Sulfate, Colitis, Ulcerative, Signal Transduction, Colon. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Ulcerative colitis (UC) is a subtype of inflammatory bowel disease. Previous studies have suggested a link between senescence process and the body's inflammatory reaction, indicating that senescence may exacerbate UC, yet the relation between UC and senescence remains unclear. Tedizolid Phosphate (TED), a novel oxazolidinone antimicrobial, is indicated in acute bacterial skin infections, its impact on senescence is not known. Our research revealed that the UC inducer dextran sulfate sodium (DSS) triggers senescence in both colon epithelial NCM460 cells and colon tissues, and TED that screened from a compound library demonstrated a strong anti-senescence effect on DSS treated NCM460 cells. As an anti-senescence medication identified in this research, TED efficiently alleviated UC and colonic senescence in mice caused by DSS. By proteomic analysis and experimental validation, we found that DSS significantly inhibits the AMPK signaling pathway, while TED counteracts senescence by restoring AMPK activity. This research verified that the development of UC is accompanied with colon tissue senescence, and TED, an anti-senescence medication, can effectively treat UC caused by DSS and alleviate colon senescence. Our work suggests anti-senescence strategy is an effective approach for UC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming 650500, Yunnan, China; School of Basic Medicine, Dali University, D…
- School of Basic Medicine, Dali University, Dali 671000, Yunnan, China.
- School of Basic Medicine, Dali University, Dali 671000, Yunnan, China. Electronic address: wxb4320062@163.com.
Zitieren
APA
Zhou, M., Liu, Z. L., Liu, J. Y., & Wang, X. B. (2024). Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway. International Immunopharmacology, 135, 112286. https://doi.org/10.1016/j.intimp.2024.112286
Vancouver
Zhou M, Liu ZL, Liu JY, Wang XB. Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway. International Immunopharmacology. 2024;135:112286. doi:10.1016/j.intimp.2024.112286
BibTeX
@article{Zhou2024,
author = {Zhou, Min and Liu, Zhen-Lin and Liu, Jia-Yu and Wang, Xiao-Bo},
title = {Tedizolid phosphate alleviates DSS-induced ulcerative colitis by inhibiting senescence of cell and colon tissue through activating AMPK signaling pathway},
journal = {International Immunopharmacology},
year = {2024},
volume = {135},
pages = {112286},
doi = {10.1016/j.intimp.2024.112286}
}
EUVIMED